•
Mar 31, 2016

Outlook Therapeutics Q2 2016 Earnings Report

Total Revenue
$995K
Previous year: $495K
+101.0%
EPS
-$32.8
Previous year: -$149
-78.0%
Gross Profit
$0
0
Cash and Equivalents
$2.84M
Total Assets
$24.8M

Outlook Therapeutics

Outlook Therapeutics